PetMed Express, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the SEC on November 10, 2026, reporting condensed consolidated balance sheet data that shows retained earnings swinging to a deficit of $3,316 thousand from a positive $9,263 thousand at March 31, 2026.

Key Highlights

  • Retained earnings turned negative: The company reported retained earnings of negative $3,316 thousand as of September 30, 2026, compared with positive $9,263 thousand as of March 31, 2026.
  • Total assets declined: Total assets were $59,403 thousand at September 30, 2026, down from $81,191 thousand at March 31, 2026.
  • Cash and equivalents fell: Cash and cash equivalents stood at $11,418 thousand, compared with $21,412 thousand at the prior fiscal year-end.
  • Inventories decreased sharply: Inventories were $6,303 thousand at September 30, 2026, down from $13,608 thousand at March 31, 2026.
  • Total shareholders' equity contracted: Shareholders' equity was $16,862 thousand, versus $28,940 thousand at March 31, 2026.
  • Shares outstanding increased: Common shares issued and outstanding were 22,131,508 at September 30, 2026, up from 21,385,638 at March 31, 2026; as of November 6, 2026, the count was 22,231,281.
  • Sales tax payable remained elevated: Sales tax payable was $18,927 thousand at September 30, 2026, versus $22,261 thousand at March 31, 2026.

PetMed Express Balance Sheet Shows Significant Equity Erosion in First Half of Fiscal 2027

According to the filing, PetMed Express, Inc. (NASDAQ:PETS) reported a condensed consolidated balance sheet as of September 30, 2026, reflecting a substantial reduction in financial position relative to its fiscal year-end of March 31, 2026. The company disclosed total assets of $59,403 thousand, a decline of approximately $21,788 thousand from the $81,191 thousand recorded at March 31, 2026. Total liabilities fell to $42,541 thousand from $52,251 thousand over the same period.

The most pronounced shift, according to the filing, was in retained earnings, which moved from a positive $9,263 thousand at March 31, 2026 to negative $3,316 thousand at September 30, 2026, a swing of $12,579 thousand. Total shareholders' equity correspondingly declined to $16,862 thousand from $28,940 thousand. The company's current liabilities at September 30, 2026 totaled $42,366 thousand, while current assets were $25,343 thousand, compared with current liabilities of $52,034 thousand and current assets of $43,564 thousand at the prior fiscal year-end.

The filing notes that PetMed Express is classified as a non-accelerated filer and a smaller reporting company. Common stock carries a par value of $0.001 per share, with 40,000,000 shares authorized. The company also disclosed that it maintains 2,500 convertible preferred shares issued and outstanding, with a liquidation preference of $4 per share, unchanged from March 31, 2026. The filing contains forward-looking statements that, according to the company's cautionary language, "involve risks, uncertainties, and assumptions, many of which, by their nature, are inherently uncertain and beyond our control."

What Was Disclosed

PetMed Express filed a Form 10-Q for the quarter ended September 30, 2026, disclosing condensed consolidated balance sheet data showing a decline in total assets, cash, inventories, and shareholders' equity, as well as a shift in retained earnings to a deficit position relative to March 31, 2026.